Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 7/20 | 0.52 |
| ▸ | PPARA | Q07869 | 7/20 | 0.52 |
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
| ▸ | KMO | O15229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4801612 | 0.88 | PPARD (0.68) | PPARDPPARAPPARG | |
| SCHEMBL4024977 | 0.83 | PPARD (0.54) | PPARDPPARAPPARGNR1H4CYP1A2 | |
| SCHEMBL4026350 | 0.83 | PPARD (0.54) | PPARDPPARAPPARGNR1H4KMO | |
| SCHEMBL3393036 | 0.83 | PPARD (0.62) | PPARDPPARAPPARGNR1H4CYP3A4 | |
| SCHEMBL4033028 | 0.83 | PPARG (0.54) | PPARDPPARAPPARGUSP2CYP1A2 | |
| SCHEMBL4025440 | 0.81 | PPARA (0.77) | PPARDPPARAPPARGKMO | |
| SCHEMBL4034567 | 0.81 | PPARG (0.53) | PPARDPPARAPPARGCRHR1USP2 | |
| SCHEMBL4028015 | 0.81 | PPARG (0.54) | PPARDPPARAPPARGCYP1A2CYP3A4 | |
| SCHEMBL4803370 | 0.81 | PPARG (0.52) | PPARDPPARAPPARGNR1H4 | |
| SCHEMBL4803451 | 0.81 | PPARD (0.59) | PPARDPPARAPPARGNR1H4KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7402597-B2 | Activator of peroxisome proliferator-activated receptor δ | NIPPON CHEMIPHAR CO., LTD (JP) | 2008-07-22 | — | — | US | disclosed |
| US-20070027196-A1 | Activator of peroxisome proliferator-activated receptor delta | SAKUMA SHOGO | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027196-A1 | Activator of peroxisome proliferator-activated receptor delta | PPARA, PPARG, PPARD | PPARD 3/4885PPARA 1/4885PPARG 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.